Skip to contentKrishnan Krish S — Krystal Biotech, Inc. insider: 339 transactions · InsiderLensKrishnan Krish S
- Director at NEW RIVER PHARMACEUTICALS INC · on record since Jan 23, 2006
- COO, CFO and Secretary at NEW RIVER PHARMACEUTICALS INC · on record since Jan 23, 2006
- Chief Operating Officer at PRECIGEN, INC. · on record since Aug 7, 2013
- Director at Krystal Biotech, Inc. · on record since Jun 5, 2026
- President and CEO at Krystal Biotech, Inc. · on record since Jun 5, 2026
- 10% owner at Krystal Biotech, Inc. · on record since Jun 5, 2026
Insider trading activity of Krishnan Krish S
- Transactions on record
- 339
- since Aug 11, 2004
- Open-market buys
- 5
- $2.3M
- Open-market sells
- 229
- $136.7M
- Companies traded
- 3
- last filing Jun 5, 2026
Figures computed from official regulatory filings — methodology.
Companies where Krishnan Krish S has traded
Track record of Krishnan Krish S
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Oct 18, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Krishnan Krish S
Co-insiders of Krishnan Krish S
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Bobo Jack APRECIGEN, INC.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 5, 2026 | Sell | -4,830 | 308.47 USD | $1.5M | SEC |
| Jun 5, 2026 | Sell | -2,784 | 309.49 USD | $861.6K | SEC |
| Jun 5, 2026 | Sell | -2,652 | 310.43 USD | $823.3K | SEC |
| Jun 5, 2026 | Sell | -964 | 311.36 USD | $300.1K | SEC |
| Jun 5, 2026 | Sell | -640 | 302.24 USD | $193.4K | SEC |
| Jun 5, 2026 | Sell | -176 | 303.17 USD | $53.4K | SEC |
| Jun 5, 2026 | Sell | -589 | 306.33 USD | $180.4K | SEC |
| Jun 5, 2026 | Sell | -544 | 304.81 USD | $165.8K | SEC |
| Jun 5, 2026 | Sell | -11,461 | 307.68 USD | $3.5M | SEC |
| Jun 5, 2026 | Sell | -320 | 300.75 USD | $96.2K | SEC |
| Jun 5, 2026 | Sell | -40 | 312.23 USD | $12.5K | SEC |
| Mar 6, 2026 | Sell | -3,128 | 260.49 USD | $814.8K | SEC |
| Mar 6, 2026 | Sell | -1,377 | 259.87 USD | $357.8K | SEC |
| Mar 6, 2026 | Sell | -2,380 | 262.44 USD | $624.6K | SEC |
| Mar 6, 2026 | Sell | -483 | 257.31 USD | $124.3K | SEC |
| Mar 6, 2026 | Sell | -2,962 | 261.41 USD | $774.3K | SEC |
| Mar 6, 2026 | Sell | -8,798 | 264.85 USD | $2.3M | SEC |
| Mar 6, 2026 | Sell | -2,043 | 263.70 USD | $538.7K | SEC |
| Mar 6, 2026 | Sell | -2,439 | 265.59 USD | $647.8K | SEC |
| Mar 6, 2026 | Sell | -920 | 266.56 USD | $245.2K | SEC |
| Mar 6, 2026 | Sell | -470 | 258.38 USD | $121.4K | SEC |
| Mar 3, 2026 | Other | -1,820 | 275.64 USD | $501.7K | SEC |
| Mar 3, 2026 | Exercise | 22,500 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | AwardD | 18,140 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | Other | -10,236 | 275.64 USD | $2.8M | SEC |